Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus in Relapsed or Metastatic Endometrial Cancer
NCT00870337Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Mar 2008
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in endometrial cancer (EC), sponsored by ARCAGY. Started Mar 2008; status: completed.
02
Drugs
everolimus
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT00870337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00870337.